Immune Checkpoint Inhibitor-Induced Colitis
Differential Diagnoses: Infectious colitis, enteritis, hyperthyroidism, ischemic colitis, celiac disease, pancreatic insufficiency, IBS, chemotherapy-induced diarrhea.
Diarrhea Grading (CTCAE):
Grade 1: <4 stools/day over baseline.
Grade 2: 4-6 stools/day, limiting instrumental ADLs.
Grade 3: ≥7 stools/day, hospitalization required, limiting self-care ADLs.
Grade 4: Life-threatening, urgent intervention needed.
Grade 5: Death.
Management Plan:
If dyspepsia, GERD, nausea present: consider EGD.
For Grade 2-4 diarrhea:
Abdominal CT to evaluate for colitis/perforation/megacolon.
NPO after midnight for colonoscopy with rush pathology.
Send labs: CBC, CMP, TSH, TTG IgA, total IgA, CRP, blood cultures (if febrile).
Stool studies: C. diff, microsporidia, bacterial culture (Salmonella, Shigella, Campylobacter, Yersinia, E. coli), ova & parasites, fecal calprotectin/lactoferrin.
IV fluids for support.
If no colitis on colonoscopy or imaging but persistent diarrhea:
Consider Loperamide 2-4mg Q4H (max 16mg/day).
Consider cholestyramine 4g BID.
If hypotensive, check lactate levels.
Steroid Therapy for Refractory Diarrhea:
Grade 2/3 diarrhea (without fever/hypotension, tolerating PO):
consider 0.5–2 mg/kg prednisone equivalent daily with a taper of 4–6 weeks
Taper by 10mg/week once improved (<4 stools/day over baseline), goal to discontinue in 6 weeks.
If no improvement in 2-3 days: Escalate to IV steroids or biologics (infliximab/vedolizumab).
Grade 4 symptoms or systemic symptoms (fever, hypotension, PO intolerance): Require urgent biologic therapy if no response within 3 days.
Discharge Criteria:
Normal vital signs (no fever, hypotension).
≤4 stools/day over baseline.
Resolution of severe abdominal pain.
Tolerance of oral diet.
GUIDELINES: AGA 2021